Publications

Research spans statistical genetics, bioinformatics, and clinical/translational research, with recent emphasis on Bayesian modelling, gene-set prioritisation, fine-mapping, and psychiatric genetics. * marks corresponding authorship.

Peer-reviewed publications

  1. Hjelholt AJ, Gholipourshahraki T, Bai Z, Shrestha M, Kjolby M, Sørensen P, Rohde PD. Leveraging genetic correlations to prioritize drug groups for repurposing in type 2 diabetes. The Pharmacogenomics Journal. 2025 Dec;25(6):33. Link

  2. Shrestha M, Bai Z, Gholipourshahraki T, Hjelholt AJ, Hu S, Kjolby M, Rohde PD, Sørensen P. Enhanced genetic fine mapping accuracy with Bayesian Linear Regression models in diverse genetic architectures. PLoS Genetics. 2025 Jul 30;21(7):e1011783. PMID: 40737338; PMCID: PMC12327644. doi:10.1371/journal.pgen.1011783

  3. Gholipourshahraki T*, Bai Z, Shrestha M, Hjelholt A, Hu S, Kjolby M, Rohde PD, Sørensen P. Evaluation of Bayesian Linear Regression models for gene set prioritization in complex diseases. PLoS Genetics. 2024 Nov 4;20(11):e1011463. doi:10.1371/journal.pgen.1011463

  4. Bai Z, Gholipourshahraki T, Shrestha M, Hjelholt A, Hu S, Kjolby M, Rohde PD, Sørensen P. Evaluation of Bayesian Linear Regression derived gene set test methods. BMC Genomics. 2024 Dec 23;25(1):1236. Link

  5. Badri S, Dadkhah-Tehrani B, Atapour A, Shahidi S, Mortazavi M, Gholipourshahraki T*. The Relationship Between Weight Indices and Blood Levels of Immunosuppressive Drugs in Renal Transplant Recipients. Iranian Journal of Pharmaceutical Research (IJPR). 2024 Sep 16;23(1):e146619.

  6. Gholipourshahraki T, Aria A, Sharifi M, Moghadas A, Moghaddas A. Potential Drug Interactions in Hospitalized Hematologic Cancer Patients: New Update with New Chemotherapy Regimens. Journal of Research in Pharmacy Practice. 2023 Oct 1;12(4):115-22.

  7. Gholipur-Shahraki T, Vahdat S, Seirafian S, Pourfarzam M, Badri S. Effect of omega-3 fatty acids supplementation on homocysteine level in patients undergoing continuous ambulatory peritoneal dialysis. Journal of Research in Pharmacy Practice. 2022 Dec 14;11(2):80.

  8. Hakamifard A, Mardani M, Nasiri MJ, Gholipur-Shahraki T*. Bendamustine and pneumocystis pneumonia: A systematic review. Health Science Reports. 2022 May;5(3):e610.

  9. Badri S, Vahdat S, Seirafian S, Pourfarzam M, Gholipur-Shahraki T*, Ataei S. Homocysteine-lowering interventions in chronic kidney disease. Journal of Research in Pharmacy Practice. 2021 Jul 1;10(3):114.

  10. Hakamifard A, Gholipur-Shahraki T*. COVID-19 and Acute Pancreatitis: A Case Report. Acta Medica Iranica. 2021 Aug 1;59(8).

  11. Gholipur-Shahraki T, Sadeghi A, Oghab P, Farrokhi P, Moghaddas A. Massive Splenomegaly: A Rare Presentation of Megaloblastic Anemia. International Journal of Hematology-Oncology and Stem Cell Research. 2021 Apr 1;15(2):132.

  12. Hakamifard A, Mardani M, Gholipur-Shahraki T*. Hemophagocytic lymphohistiocytosis presented with fever of unknown origin: A case study and literature review. Clinical Case Reports. 2021 Apr;9(4):2350-5.

  13. Kazemi R, Gholipur-Shahraki T, Salehi H, Hatampour M, Ghadimi K. Spontaneous nephrocutaneous fistula due to xanthogranulomatous pyelonephritis with secondary enterocutaneous fistula: a rare case report. American Journal of Clinical and Experimental Urology. 2021;9(2):177.

  14. Gholipour-Shahraki T, Yari F, Seirafian S, Badri S. Potential of drug interactions as a cause of adverse drug reactions in patients with kidney diseases. Journal of Research in Pharmacy Practice. 2020 Apr;9(2):121.

  15. Ashtari F, Hakamifard A, Hariri A, Gholipour-Shahraki T. Rituximab associated necrosis: A case report. Multiple Sclerosis and Related Disorders. 2020 Jan 1;37:101429.

  16. Hakamifard A, Mousavi S, Gholipur-Shahraki T*, Mohaghegh F. Levofloxacin Induced Stomatitis: A Case Report. Journal of Pharmaceutical Care. 2019 Oct

  17. Gholipur-Shahraki T, Feizi A, Mortazavi M, Badri S. Effects of carnitine on nutritional parameters in patients with chronic kidney disease: an updated systematic review and meta-analysis. Journal of Research in Pharmacy Practice. 2018 Apr;7(2):5.

Preprints

  1. Gholipourshahraki T*, Barry CJ, Plana-Ripoll O, Bulik C, Benros ME, Bo Mortensen P, Agerbo E, Vogdrup Petersen L, Johann Vilhjalmsson B. Estimating Within- and Between-Family Polygenic Effects For Psychiatric Disorders Under Non-random Ascertainment. medRxiv. 2026. Read preprint

  2. Gholipourshahraki T*, Ejlskov L, Semark BD, Maseras GT, Steinbach J, Hansen OS, Pedersen CB, Bulik CM, Benros ME, Mortensen PB, Agerbo E. Polygenic Scores and Environmental Factors in Psychiatric Disorders: Gene–Environment Interaction Analyses Using the iPSYCH Study. medRxiv. 2025 Oct 8. Read preprint

  3. Pre-release notes for Genomic Informed Drug Target Database (Pre-release). Zenodo. doi:10.5281/zenodo.7925231

In preparation

  1. Gholipourshahraki T*, et al. Estimating within- and between-family polygenic effects for psychiatric disorders under selection bias.
  2. Barry CJ, Gholipourshahraki T, Kutalik Z, Vilhjálmsson BJ, Agerbo E. Statistical Approaches to Selection Bias in Genetic Epidemiology: A Systematic Review.

Books

  1. Borran M, Gholipurshahraki T, Arbabi B. (2021). Ambulatory Care Therapeutics and Pharmacotherapy; Psychiatric Disorder. Abadis Teb. (in Persian)

Conference contributions

Seven poster presentations, 2019–2026, including a Best Poster Award nomination at the European Society of Human Genetics (ESHG) conference, 2025.